Favorable Safety Profile of Tirbanibulin Ointment 1% for Actinic Keratosis: Pooled Results from Two Phase III Studies. (2020). SKIN The Journal of Cutaneous Medicine, 4(6), s120. https://doi.org/10.25251/skin.4.supp.120